APA (7th ed.) Citation

Popat, R., Moreau, P., Usmani, S. Z., Garfall, A., Mateos, M., San-Miguel, J. F., . . . Donk, N. W. v. d. (2022, June). P922: HEALTH-RELATED QUALITY OF LIFE WITH TECLISTAMAB, A B-CELL MATURATION ANTIGEN X CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA FROM MAJESTEC-1. HemaSphere.

Chicago Style (17th ed.) Citation

Popat, R., et al. "P922: HEALTH-RELATED QUALITY OF LIFE WITH TECLISTAMAB, A B-CELL MATURATION ANTIGEN X CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA FROM MAJESTEC-1." HemaSphere Jun. 2022.

MLA (9th ed.) Citation

Popat, R., et al. "P922: HEALTH-RELATED QUALITY OF LIFE WITH TECLISTAMAB, A B-CELL MATURATION ANTIGEN X CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA FROM MAJESTEC-1." HemaSphere, Jun. 2022.